A double blind, randomized, parallel, cross-over comparision of glycemic control achieved with once a day insulin glargine versus detemir in type 2 diabetes

Trial Profile

A double blind, randomized, parallel, cross-over comparision of glycemic control achieved with once a day insulin glargine versus detemir in type 2 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Nov 2010

At a glance

  • Drugs Insulin detemir; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Sep 2008 Results presented at the 44th Annual Meeting of the European Association for the Study of Diabetes
    • 08 Jun 2008 Status changed from recruiting to completed according to Novo Nordisk.
    • 08 Jun 2008 Results were presented at the American Diabetes Association's 68th Annual Scientific Sessions (ADA).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top